Read the full article here.
This content was originally published by IoL Business Report. Original publishers retain all rights. It appears here for a limited time before automated archiving. By IoL Business Report
JSE-listed drug maker Aspen Pharmacare reported a 3percent increase in revenue to R18.4billion for the six months to end December.